News|Webcasts|April 15, 2024

Complex Trials, Clear Budgets: Global Clinical Trial Budgeting Strategies

Author(s)IQVIA

Webinar Date/Time: Wednesday, May 22, 2024 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Elevate your clinical trial budgeting skills with IQVIA Technologies’ expert insights. Learn to navigate the complexities of multi-country trials and accelerate your budget finalization.

Register Free: https://www.appliedclinicaltrialsonline.com/act/trial-budgeting-strategies
Event overview

Join IQVIA Technologies for an informative webinar exploring the intricacies of clinical trial budgeting. As trials continue to grow in complexity and scale, understanding budget building best practices is crucial.

This presentation considers the complexities of conducting trials across multiple countries and sites, and the growing demand for accelerating budget finalization to bring much needed medications and therapies into the market quicker. Don’t miss your chance to learn about strategies on effective budget building methods and how technology can provide a comprehensive solution for managing investigator grant costs.

Three key take-aways

  • Discuss the complexities of managing clinical trial budget development and finalization and their impact on study start-up.
  • Gain insights into effective methods for clinical trial budgeting, highlighting the importance of real-time projections, technology, and consistent processes across studies.
  • Explore the role of technology in managing investigator grant costs.

Speakers:

Brenda Mull
Associate Director, Business Operations, Cost Benchmarking
IQVIA Technologies
Brenda Mull leads the Cost Benchmarking operations team and is the business owner of the GrantPlan suite of products, which offers best-in-class budget development solutions for sponsors, CROs and investigators. She has more than a decade of experience in contracting and budget negotiations for clinical trial study start-up, with deep knowledge and a strong focus on budget development. With more than 30 years in the healthcare industry, she is passionate about bringing technology to the clinical trial space to assist with life-changing solutions.

Jyothsna Gade
Associate Director, Product Management, Cost Benchmarking
IQVIA Technologies
Jyothsna is a seasoned professional with over 20 years of experience leading diverse product teams. She is dedicated to providing cutting-edge solutions, consistently emphasizing innovation to ensure that technology aligns seamlessly with the evolving requirements of the clinical trial domain. Jyothsna leads the cost benchmarking product team at IQVIA, with a primary focus on GrantPlan, a trial-budgeting solution to help sponsors, CROs and sites.


Register Free: https://www.appliedclinicaltrialsonline.com/act/trial-budgeting-strategies


Related to this article

© photon_photo - © photon_photo - stock.adobe.com
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
© putilov_denis - © putilov_denis - stock.adobe.com
Real-time clinical trials require standardized digital data capture at the point of care through scaled eSource-EDC-EHR integration, but progress stalls because competing standards lack regulatory enforcement and one-off system integrations cannot scale beyond single studies without industry-wide alignment and legal clarity on data ownership.
What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, argues that CROs must act as orchestrators rather than aggregators—and that the real test of any AI ecosystem is whether it reduces sponsor coordination burden or just hands it back to them.
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.